Updated September 4 at 4:04pm
Life Sciences
60 results total, viewing 31 - 40
MedMates, a healthcare technology network group, is holding a New Year social mixer and networking event on Jan. 13 from 5:30 to 7:30 p.m. at Flat Bread Co., 161 Cushing St. more
Moderna Therapeutics has announced another record venture capital investment: $450 million. more
EpiVax Inc. and Novozymes Biopharma entered into a license agreement for the development of treatments for autoimmune diseases, the companies announced on Monday. more
A Cherrystone Angel Group portfolio company, Windgap Medical Inc., was awarded nearly $1 million through a Massachusetts Life Sciences Center accelerator loan program. more
The recent change in leadership at IlluminOss Medical, a commercial stage medical device company focused on minimally invasive orthopedic fracture repair, reflects its changing direction, according to those familiar with the company. more
PROVIDENCE – Brown University researchers say infectious-disease outbreaks appear to be on the rise globally, though on a per capita basis, the impact is declining. more
(Updated, 5:14 p.m.) A Cherrystone Angel Group portfolio business has entered into an acquisition agreement of $140 million with a European buyer specializing in bio-analytical testing and genomic services. more
WOODS HOLE, Mass. – The Woods Hole Oceanographic Institution accepted the largest single monetary award in its history to create a system of offshore, remotely controlled, ocean observatories, the Cape Code Times reported. more
Leaders of Neighborhood Health Plan of Rhode Island say strong growth of the company’s patient base, staff and revenue highlight growing community needs prioritized by nationwide health care reform. more
IlluminOss Medical has received conditional approval from the federal Food and Drug Administration to conduct a clinical trial for treatments of impending and pathologic fractures in the humerus due to metastatic carcinoma. more
« Prev | 1 | 2 | 3 | 4 | 5 | 6 Next »